Name: U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit
Brand: reuters.com
SKU: reuters-com-1786
Availability: OnlineOnly

critic

U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit

preview

By , (Reuters) - Twenty-six drug manufacturers were sued on Wednesday by the attorneys general of most U.S. states and several territories, which accused them of conspiring to reduce competition and drive up generic drug prices.Slideshow The lawsuit accused Novartis’ Sandoz unit, Teva Pharmaceuticals’ Actavis unit, Mylan, Pfizer Inc and other drugmakers of conspiring to rig the market between 2009 and 2016 for more than 80 drugs.Attorneys general from 46 states, the District of Columbia and four U.S. territories said the defendants prioritized profit over the public interest, depriving millions of consumers of lower prices for needed medication.Ten executives, including many sales and marketing directors, are also defendants in the 543-page complaint filed in a federal court in Connecticut.Novartis spokesman Eric Althoff said the instances of misconduct related to its $195 million settlement with the U.S. Department of Justice in March “do not support the vast, systemic conspiracy the states allege.”The settlement resolved allegations Novartis fixed generic drug prices between 2013 and 2015.Pfizer spokeswoman Sally Beatty said the drugmaker did not believe it engaged in unlawful conduct. Mylan spokeswoman Lauren Kashtan said her company had found no evidence of price fixing. Teva did not immediately respond to requests for comment.The lawsuit follows similar cases over generic drug prices brought in 2016 and 2019, and which remain pending.Brand names of some of the drugs at issue include glaucoma drug Xalatan, acne drug Differin, anti-seizure medicine Dilantin, anti-fungal medicine Lotrimin AF Cream, and Ritalin for attention deficit disorder.“Through phone calls, text messages, emails, corporate conventions, and cozy dinner parties, generic pharmaceutical executives were in constant communication, colluding to fix prices and restrain competition,” Connecticut Attorney General William Tong said. “They took steps to evade accountability.”Reporting by Diane Bartz and Jonathan Stempel; Additional reporting by Ankur Banerjee and Caroline Humer; Editing by David Gregorio and Richard ChangOur Standards:

By , (Reuters) - Twenty-six drug manufacturers were sued on Wednesday by the attorneys general of most U.S. states and several territories, which accused them of conspiring to reduce competition and drive up generic drug prices.Slideshow The lawsuit accused Novartis’ Sandoz unit, Teva Pharmaceuticals’ Actavis unit, Mylan, Pfizer Inc and other drugmakers of conspiring to rig the market between 2009 and 2016 for more than 80 drugs.Attorneys general from 46 states, the District of Columbia and four U.S. territories said the defendants prioritized profit over the public interest, depriving...

public

I cover antitrust for Reuters. Ex-AFP, AP and UPI. Minnesota native; talk lefse to me. Diane.Bartz@reuters.com. I only read people who properly use apostrophes.

Diane Bartz

Jonathan Stempel

Top and breaking news, pictures and videos from Reuters. For more breaking business news, follow @ReutersBiz.

reuters.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS